Current BSL TMS Clinical Trials

Contact Berry Anderson, RN, or Samet Kose, MD, if you are interested in participating in a TMS study.
andersob@musc.edu, kose@musc.edu
843 876 5142


Important News  Regarding the  FDA Panel on TMS for Depression


Thanks to the Patients Who Have Participated in  TMS Clinical Trials
    In light of the upcoming FDA panel hearing on potentially approving TMS as a treatment of depression, we thought we would make available here the first published article concerning prefrontal TMS for the treatment of depression. (Remember there were at least thre prior case reports of stimulating the top of the brain as a treatment. This has not been followed up on). We gratefully acknowledge the help and participation of this first patient (who was in the NIMH hospital in Bethesda, MD, at the time), as well as all other patients who have volunteered in TMS trials. Without patient participation and collaboration, it is not  possible to develop new treatments. Thanks.

Here is the first published article concerning prefrontal TMS for the treatment of depression.
        George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM: Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995, 6:1853-1856.

Here is a color version  of the figure.